Cardiorespiratory Research

Group Leader(s): Dr Shakeeb Moosavi

Contact: smoosavi@brookes.ac.uk +44 (0)1865 483257

About us

Our work explores functional interactions between the brain, lungs and the heart with particular focus on neurophysiological mechanisms underpinning the perception of breathlessness ('dyspnoea'). The aim of the research is to find out how breathlessness ('dysponea') arises so that more effective drugs can be developed to relieve dysponea when the underlying disease can't be cured.

We study healthy individuals in whom we can experimentally induce various forms of breathlessness, and clinical populations in collaboration with Cardiology, Respiratory Medicine and Clinical Neuroscience at Oxford University Hospitals.

The group has a three-pronged research strategy:

  1. To study patients undergoing neurological interventions or suffering neurological damage in order to better understand neurophysiological mechanisms of breathlessness.
  2. To use the improved understanding of neurophysiological mechanisms of breathlessness to identify and trial new pharmacological interventions for intractable breathlessness.
  3. To address emerging concerns in clinical physiology, particularly those that have the potential to stretch the NHS to breaking point.

Dr Moosavi with a study participant

Research impact

Dyspnea 2022 Conference Logo showing the Headington Shark Sculpture

Working Towards Better Symptom Management

Improving our understanding of the breathlessness neural network in the brain will lead to better management of intractable breathlessness in patients with chronic conditions. 

The Development of the Dyspnea-12 Measure 

Dr. Moosavi was part of the team that developed the Dyspnea-12, a gold standard tool used worldwide to assess the severity and bothersomeness of breathlessness in clinical practice.

The Impact of Subthalamic Nucleus Deep Brain Stimulation (STN DBS) on Breathlessness

Many patients develop breathlessness after undergoing subthalamic nucleus Deep Brain Surgery, especially when the electrodes are switched on. Pioneering research by the group has identified that stimulating specific brain areas, such as the subthalamic nucleus and thalamus, can increase or decrease breathlessness.

Discovery of Insensitivity to Breathlessness Post-Surgery

The research group was the first to discover that some DBS patients lose the ability to feel changes in their breathlessness after surgery, leaving them unaware if their condition worsens. Dr. Moosavi advocates for routine breathing and breathlessness tests for patients with neurological conditions or those undergoing DBS surgery. These checks are crucial to identify those who have become insensitive to breathlessness (such as Thalamic DBS patients) and ensure proper monitoring to prevent health deterioration. Without the breathlessness warning, a patient may unknowingly allow a virus or chest infection to worsen, complicating treatment.

Special Collection and International Conference

The group was invited by Frontiers in Neuroscience to guest-edit a special collection of articles on Respiratory control and dysfunction in neurological patients. Additionally, they co-hosted the 6th International Dyspnea Conference in July 2022 with colleagues from Oxford and Cambridge.

Find out more about breathlessness research in the Dyspnea podcast series.

Leadership

Shakeeb Moosavi

Dr Shakeeb Moosavi

Reader in Clinical Physiology

View profile

Publications